Full name
BIOVETA POLSKA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
73.20.Z - Market research and public opinion polling
21.10.Z - Manufacture of basic pharmaceutical substances
21.20.Z - Manufacture of medicines and other pharmaceutical products
46.46.Z - Wholesale of pharmaceutical goods
52.10.B - Warehousing and storage of other goods
58.14.Z - Publishing of journals and periodicals
63.99.Z - Other information service activities not elsewhere classified
85.60.Z - Educational support activities
96.09.Z - Other personal service activities not elsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | -0,1 | -0,1 | 0,2 | 381,6 |
EBITDA | 0 | 0 | 0,2 | 8435,1 |
Short time liabilities | 0,1 | 0,1 | 0 | -68,4 |
Equity capital | 0,1 | 0 | 0,2 | 422,9 |
Operating profit (EBIT) | -0 | -0 | 0,2 | 860,6 |
Assets | 0,3 | 0,3 | 0,2 | -22,2 |
Net profit (loss) | -0,1 | -0,1 | 0,2 | 381,6 |
Cash | 0,1 | 0,1 | 0,1 | -9,1 |
Liabilities and provisions for liabilities | 0,2 | 0,3 | 0 | -89,7 |
Net income from sale | 1,2 | 1,2 | 1,1 | -11,1 |
Working assets | 0,2 | 0,3 | 0,2 | -12,4 |
Depreciation | 0 | 0 | 0 | 23,9 |
% | % | % | p.p. | |
Profitability of capital | -64,4 | -150,2 | 80,9 | 231,1 |
Equity capital to total assets | 33,9 | 13,2 | 88,5 | 75,3 |
Gross profit margin | -5,7 | -5,2 | 16,5 | 21,7 |
EBITDA Margin | 0,3 | 0,2 | 21,6 | 21,4 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 29 | 27 | 10 | -17 |
Current financial liquidity indicator | 1.0255823135375977 | 8.683396339416504 | 7,7 | |
Net dept to EBITDA | -40.35097122192383 | -0.4322534501552582 | 40 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane